HKEx Stock Code: 01093English|繁體|简体
Strategies

Innovative drug business

  • Continued investments in R&D to further enrich our product pipeline, focusing on cardio-cerebrovascular, neurology, oncology, anti-infective and diabetes therapeutic areas

  • Further research and development efforts to foster blockbuster drugs

  • Expand market potential and sales of existing innovative products by using academic-based market promotion


Bulk drug business

  • Focus on the development of industry-leading bulk drug products, further increase market share, reduce costs, and continue to develop high-quality customer base in order to further enhance our leading position in the industry


International expansion

  • Obtain overseas certification

  • Seek to establish strategic partnerships internationally to gain access to advanced technologies, patents and sales channels overseas.

  • Continue to pursue a strategy to introduce pharmaceutical products from overseas into China in parallel with the goal of exporting more of our products overseas via such partnerships and collaborations


M&A

  • Consider strategic M&A opportunities to further strengthen our product portfolio within existing therapeutic areas, enter into new therapeutic areas as well as to further enhance our sales and marketing capabilities
© Copyright 2017 CSPC Pharmaceutical Group Limited. All Rights Reserved.